Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Sleep Apnea Syndromes

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Sleep Apnea Syndromes in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, RC1
Row, BW1
Gozal, E1
Kheirandish, L1
Fan, Q1
Brittian, KR1
Guo, SZ1
Sachleben, LR1
Gozal, D1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Sleep Apnea Syndromes

ArticleYear
Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat.
    American journal of respiratory and critical care medicine, 2003, Aug-15, Volume: 168, Issue:4

    Topics: Analysis of Variance; Animals; Apoptosis; Cerebral Cortex; Cyclooxygenase 1; Cyclooxygenase 2; Cyclo

2003